166 related articles for article (PubMed ID: 18071292)
1. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.
Yamamoto R; Takaori-Kondo A; Kanda J; Imada K; Ichinohe T; Ishikawa T; Ohmori K; Uchiyama T
Bone Marrow Transplant; 2008 Mar; 41(6):591-3. PubMed ID: 18071292
[No Abstract] [Full Text] [Related]
2. Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab.
Benson DM; Smith MK; Krugh D; Devine SM
Bone Marrow Transplant; 2008 Mar; 41(6):595-6. PubMed ID: 18037934
[No Abstract] [Full Text] [Related]
3. Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation.
Meniane JC; El-Cheikh J; Faucher C; Fürst S; Bouabdallah R; Blaise D; Mohty M
Bone Marrow Transplant; 2007 Jul; 40(2):175-7. PubMed ID: 17502896
[No Abstract] [Full Text] [Related]
4. Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Kyriakou C; Canals C; Cornelissen JJ; Socié G; Willemze R; Ifrah N; Greinix HT; Blaise D; Deconinck E; Ferrant A; Schattenberg A; Harousseau JL; Sureda A; Schmitz N
J Clin Oncol; 2010 Nov; 28(33):4926-34. PubMed ID: 20956626
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic large cell lymphoma in leukemic transformation: successful treatment by transplantation.
Wu SJ; Yao M; Tien HF; Tang JL; Lin CW; Chen YC
J Clin Oncol; 2007 Oct; 25(28):4490-2. PubMed ID: 17906210
[No Abstract] [Full Text] [Related]
6. Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.
Puig N; Caballero MD; Alcoceba M; Sebastián E; Balanzategui A; Sarasquete ME; García-Sanz R; González-Díaz M
Ann Hematol; 2011 Feb; 90(2):227-9. PubMed ID: 20506021
[No Abstract] [Full Text] [Related]
7. [Membranous nephropathy following allogeneic peripheral blood stem cell transplantation in a boy with anaplastic large cell lymphoma].
Park YD; Hamada M; Higuchi B; Kishimoto T; Inagaki J; Nishiguchi M; Shimoyama H; Nakajima M; Nakagawa A; Yoshioka A
Rinsho Ketsueki; 2004 Nov; 45(11):1193-7. PubMed ID: 15609686
[TBL] [Abstract][Full Text] [Related]
8. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
[TBL] [Abstract][Full Text] [Related]
9. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
10. Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B-cell lymphoma.
Goto H; Nishio M; Endo T; Sato N; Koizumi K; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
Eur J Haematol; 2005 Jun; 74(6):526-8. PubMed ID: 15876258
[TBL] [Abstract][Full Text] [Related]
11. High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
Hamadani M; Benson DM; Lin TS; Porcu P; Blum KA; Devine SM
Eur J Haematol; 2008 Dec; 81(6):425-31. PubMed ID: 18774954
[TBL] [Abstract][Full Text] [Related]
12. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
Jantunen E; Canals C; Rambaldi A; Ossenkoppele G; Allione B; Blaise D; Conde E; Tilly H; Cook G; Clark F; Gallamini A; Haynes A; Mounier N; Dreger P; Pfreundschuh M; Sureda A;
Haematologica; 2008 Dec; 93(12):1837-42. PubMed ID: 18838474
[TBL] [Abstract][Full Text] [Related]
14. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
[TBL] [Abstract][Full Text] [Related]
15. Warburg effect associated with transformed lymphoplasmacytic lymphoma to diffuse large B-cell lymphoma.
Buppajarntham S; Junpaparp P; Kue-A-Pai P
Am J Emerg Med; 2013 Jun; 31(6):999.e5-6. PubMed ID: 23478115
[TBL] [Abstract][Full Text] [Related]
16. Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-
Maffini E; Anderson LD; Sandmaier BM; Green DJ; Storer BE; Niederwieser D; Maziarz RT; Maloney DG; Storb R
Haematologica; 2018 Jun; 103(6):e252-e255. PubMed ID: 29545343
[No Abstract] [Full Text] [Related]
17. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
[TBL] [Abstract][Full Text] [Related]
18. Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphoma.
Sawamoto A; Narimatsu H; Suzuki T; Kurahashi S; Sugimoto T; Sugiura I
Bone Marrow Transplant; 2006 Jan; 37(2):233-4. PubMed ID: 16284609
[No Abstract] [Full Text] [Related]
19. High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.
Bloor AJ; Thomson K; Chowdhry N; Verfuerth S; Ings SJ; Chakraverty R; Linch DC; Goldstone AH; Peggs KS; Mackinnon S
Biol Blood Marrow Transplant; 2008 Jan; 14(1):50-8. PubMed ID: 18158961
[TBL] [Abstract][Full Text] [Related]
20. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]